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ABSTRACT 
Repeated  thrombin  treatment  of  washed  platelets  prepared  from  rabbits  can 
decrease the serotonin content of the platelets by about 80%. When these platelets 
are  deaggregated  they  reaccumulate  serotonin  but  their  storage  capacity  for 
serotonin is reduced by about 60%. If thrombin-pretreated platelets are allowed to 
equilibrate with a high concentration of serotonin (123 ~,M), they release a smaller 
percentage of their total serotonin upon further thrombin treatment, in comparison 
with the percentage of serotonin  released from control platelets equilibrated  with 
the same concentration of serotonin. Calculations indicate that in thrombin-treated 
platelets reequilibrated with serotonin, two-thirds of the serotonin is in the granule 
compartment and one-third  is in the extragranular compartment, presumably the 
cytoplasm. Analysis of the exchange of serotonin between the suspending fluid and 
the platelets  showed that thrombin treatment does not alter the transport rate of 
serotonin across the platelet membrane, and does not cause increased diffusion of 
serotonin  from the platelets into the suspending fluid. The primary reason for the 
reduced  serotonin  accumulation  by the thrombin-treated  platelets  appears to be 
loss of amine storage granules or of the storage capacity within the granules. 
Rabbit platelets that have been degranulated and 
aggregated  by treatment  with  thrombin  in  vitro 
can be recovered as single platelets (Reimers et al., 
1973). These thrombin-treated platelets aggregate 
upon the addition of low concentrations of ADP, 
and upon reinfusion  into rabbits they survive for a 
normal  length  of time.  In  these  experiments the 
platelets lost more than 60% of the serotonin and 
adenine nucleotides  from their amine storage gran- 
ules,  but it appeared that the thrombin treatment 
of the platelets did not lead to irreversible damage 
which caused changes in platelet survival or loss of 
responsiveness to  ADP.  We have now  examined 
the  transport  and  storage  of serotonin  by these 
thrombin-degranulated platelets. 
Several investigators have postulated that sero- 
tonin  interacts  with  a  receptor  on  the  platelet 
membrane, and have provided evidence  that it is 
transported  across  the  membrane  by  an  active 
process, and appears in the amine storage granules 
(Hardisty and  Stacey,  1955; Born  and  Bricknell, 
1959; Born and Gilison,  1959; Hughes and Brodie, 
1959;  Tranzer  et  al.,  1966;  Pletscher,  1968; 
Pletscher  et  al.,  1971; Baumgartner  and  Born, 
1969; Baumgartner,  1969; Okuda and Nemerson, 
1971;  Sneddon,  1973). Serotonin  also  diffuses 
from  the  platelets  into  the  suspending  medium 
(Hughes and Brodie,  1959; Okuda and Nemerson, 
1971).  All  of the  platelet  serotonin  is  freely ex- 
changeable  with  serotonin  in  the  medium  (Born 
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1973). 
The  experiments  reported  in  this  paper  were 
designed  to examine  whether the thrombin treat- 
ment  of platelets interfered with  the transport of 
serotonin  across  the  platelet  plasma  membrane 
into  the  cytoplasm,  the  diffusion  from  the  cyto- 
plasm into the suspending fluid, or the uptake from 
the cytoplasm into the amine storage granules. 
MATERIALS  AND  METHODS 
Nonradioactive  Compounds 
Thrombin was crude bovine thrombin (Parke, Davis & 
Company,  Detroit,  Mich.).  p-Tosyl-L-arginine  methyl 
ester  (HCI)  (TAMe)  was  obtained  from  ICN  Phar- 
maceuticals Inc., Life Sciences Group (Cleveland, Ohio). 
Prostaglandin E1 (PGEt) was generously supplied by the 
Upjohn Co.  (Kalamazoo, Mich.). ADP and 5-hydroxy- 
tryptamine creatinine sulfate complex (5HT; serotonin) 
were obtained from the Sigma Chemical Co. (St. Louis, 
Mo.). Trypsin-activated pig plasmin was obtained from 
Novo-Fabrik,  Copenhagen,  and  was dissolved in 0.9% 
NaCI (0.5 g/100 ml). Apyrase was prepared according to 
Molnar and Lorand (1961).  Minimum essential medium 
(Eagle's medium; catalog no. F-I 1) was purchased from 
Grand  Island  Biological  Co.,  Grand  Island,  N.  Y. 
Reserpine (Serpasil) was  obtained from Ciba Co.  Ltd. 
(Dorval, Quebec);  1 ml aqueous solution contained 15 
mg  reserpine.  Imipramine  (Tofranil) was  obtained  as 
powder from Geigy Canada Ltd. and dissolved in 0.85% 
saline. 
Radioactive  Compounds 
[G-3H]5-Hydroxytryptamine  creatinine  sulfate 
([SH]serotonin; [SH]5HT) in aqueous solution containing 
2% ethanol (specific activity approximately 11 Ci/mmol) 
and  [Y-l~C]5-hydroxytryptamine  creatinine  sulfate 
([~C]serotonin;  [~'C]5HT)  (specific  activity  approxi- 
mately 50 mCi/mmol), were obtained from Amersham/ 
Searle Corp.  (Arlington Heights,  II1.). The  radioactive 
purity  of the  [~'C]5HT  was  determined  by the  paper 
chromatographic method of Pletscher et al. (1968) and 
was found to be between 82 and 91% at the time of its 
use. [carboxy-~'C]5-Hydroxy-3-indoleacetic acid ([~C]5- 
hydroxyindoleacetic acid;  [~'C]5HIAA) was  purchased 
from New  England Nuclear (Boston,  Mass.). The spe- 
cific activity of the [~4C]5HIAA was  10 mCi/mmol. 
Platelet Suspensions 
Suspensions  of washed  platelets  in  Tyrode  solution 
containing albumin (0.35%)  and apyrase were prepared 
from rabbit blood as described by Ardlie et al. (1971).  In 
experiments in which the pH was expected to fall, Eagle's 
medium  was  used  instead of Tyrode  solution. Suspen- 
sions  of  thrombin-treated  platelets  were  prepared  as 
described previously (Reimers et al.,  1973): platelets in 
20 ml of Tyrode-albumin solution (1.5  ￿  109 platelets/ 
ml) were aggregated by the addition of thrombin (0.05 
U/ml). After large aggregates had formed, PGEa (1 #M) 
and TAMe (1 mM) were added. Within 30 rain at 37~ 
the platelets deaggregated. Platelets were washed once in 
calcium-free  Tyrode-albumin  and  then  resuspended  in 
Tyrode  solution  containing apyrase  and  albumin. The 
procedure was repeated twice. 
Platelet Release Reaction 
This reaction was studied using platelets labeled with 
[~4C]5HT as described previously (Packham et al., 1967). 
1 ml of platelet suspension (1.0  ￿  109 platelets/ml) was 
warmed at 37~  for 5 min and then incubated with the 
control solution (Tyrode) or with the thrombin solution 
(0.1  ml)  for  3  rain  at  37~  in  a  shaking device.  The 
suspension  was  transferred  rapidly  into  an  Eppendorf 
centrifugation tube and centrifuged for 1 min at 15,000 g 
in  an  Eppendorf microcentrifuge  3200.  The  supernate 
was  stored  in  an  ice  bath.  Samples  were  taken  for 
radioactivity determination. 
Studies  of [~C]Serotonin  A ccumulation 
[~'C]5HT  (0.8  #Ci/#mol) in 0.2 ml Tyrode solution 
was  added  to  10-ml  platelet  suspension  (l.0  ￿  l0  s 
platelets/~tl) to give a final concentration of 123 ~tM. The 
radioactivity in an aliquot of the total platelet suspension 
and in an aliquot of the  15,000 g supernate (Eppendorf 
centrifuge 3200;  45 s) was determined at various times. 
The difference between the two  radioactivity measure- 
ments was taken as a measure of [~'C]serotonin accumu- 
lation within the platelets.  In studies with inhibitors of 
serotonin accumulation, the inhibitor (or Tyrode solution 
in the control) was added 5 min before the addition of 
[14C]5HT  to  the platelet suspension.  Experiments were 
performed at 37~ 
The accumulation of [~4C]5HIAA (final concentration 
0.5 and 5.0 tzM) was studied in the same way. 
Studies  of [l~C]Serotonin Reaccumulation 
after the Release Reaction 
Thrombin  (0.05  U/ml)  was  added  to  20  ml  of  a 
suspension of washed platelets (1.5  ￿  l0  g platelets/ml) 
that had been labeled with [I~C]5HT  in the first washing 
fluid. After large aggregates had formed, aliquots were 
taken and the released  radioactivity was determined in 
the supernatant fluid. Disappearance of the radioactivity 
from the surrounding medium upon addition of Tyrode 
solution  (control) or  PGE~  (1  ~,M)  was  measured.  All 
experiments were performed at 37~ 
If aggregation  and  release  of  ~4C  were  induced  by 
addition of a  high thrombin concentration (0.5  U/ml), 
fibrin  formed  and  bound  the  platelets  together.  To 
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min (0.5 mg/ml) was added with PGE~. 
Assays of Radioactivity 
The amount of radioactivity in the platelet suspensions 
(for total  radioactivity) or in  the supernatant  solutions 
was determined as described previously (Jenkins et al., 
1971).  In experiments in  which a  double-labeling tech- 
nique was used the specific activities of the [3H]5HT (8.8 
mCi/mmol)  and  [t4C]5HT  (176  #Ci/mmol)  were  ad- 
justed so that  in each sample in which the radioactivity 
was measured the number of cpm in the SH channel was 
approximately  5-10  times greater than  that  in  the  ~'C 
channel. Sufficient counts were accumulated to obtain a 
radioactivity  determination,  in  each  sample,  with  an 
error of less than • 
Platelet Serotonin and 
Serotonin Metabolites 
Platelet  serotonin  was  measured  fluorometrically 
using the method described by Weissbach et al. (1958). In 
experiments  in  which  serotonin  accumulation  or  the 
platelet  storage  capacity  for  serotonin  was  measured, 
platelets  were  incubated  with  serotonin  for  different 
lengths  of  time  and  the  serotonin  concentration  was 
determined in the total platelet suspensions as well as in 
the supernatant  fluid.  Platelet serotonin was calculated 
from the difference between these values. Although the 
fluorometric  method  used  measures  all  5-hydroxyin- 
doles,  the platelet  serotonin content may  be estimated 
with  reasonable  accuracy  from  the  difference between 
total 5-hydroxyindoles and supernatant 5-hydroxyindoles 
since it  could  be shown  in  experiments with  [t~C]5HT 
that  only  small  amounts  of  serotonin  metabolites 
(5HIAA; 5-hydroxytryptophol [5HT'ol]) were within the 
platelets under all experimental conditions (less than 10% 
of the total platelet radioactivity). Most of the serotonin 
metabolites were  found  in  the supernatant  fluid.  Sero- 
tonin  in  the  washed platelet pellet was  not determined 
directly because, according to Born and Gillson (1959), 
there is a partial loss of serotonin from human platelets 
into the surrounding medium during each washing step, 
and  it  was  found  that  this  occurred  also  with  rabbit 
platelets when they had been incubated with serotonin at 
a  high concentration. 
Radioactive serotonin and  its metabolites were sepa- 
rated  by paper chromatography (Pletscher et al.,  1968) 
and quantitated  by liquid scintillation counting. 
Analysis of  Serotonin Exchange Experiments 
The exchange of serotonin between platelets and the 
suspending medium was carried out with two radioactive 
tracers, 14C and 3H.  At the beginning of the experiments 
the  [SH]serotonin  is  within  the  platelet,  and  the 
[~4C]serotonin  is  in  the  suspending medium.  The  sero- 
tonin exchange data are obtained as counts of ~C and 3H 
radioactivity  in  the  surrounding  medium.  These  data 
may  be  converted to  the  fraction  of total  t~C  and  ~H 
radioactivity in the platelet suspension. It is assumed that 
the  platelet  suspension  contains  three  compartments: 
suspending  medium  (compartment  1);  "cytoplasm" 
(compartment 2); and storage granules (compartment 3): 
Compartments I and 3 are connected through compart- 
ment 2.  The  fraction of the serotonin in  any compart- 
ment that is transferred to another compartment in 1 rain 
is the  fractional turnover  rate  between these two com- 
partments. The  fractional turnover rate  from compart- 
ment  1  to  compartment  2  is  a~,  etc.  The  fractional 
turnover rates are  assumed to  he equal  for radioactive 
and  nonradioactive serotonin. The  fraction of tracer in 
compartment  1 (the surrounding medium) is m~ and may 
be described by the following equations: 
[l'C]rn~  =  A  +  BeX, ,  +Ce~  t  (1) 
[SH]mt  =  A  +  De~,t  +  EeX, t  (2) 
where the preexponential constants A, B, C, D, and E are 
functions of the  initial tracer distribution and the frac- 
tional turnover rates, whereas the exponential constants, 
,k~ and ,~, are functions of the fractional turnover rates 
alone. 
The  initial distribution  of ~C  being  known,  all  this 
tracer lying within the surrounding medium, it is possible 
to determine the fractional turnover rates from the  "C 
data  set  by  fitting  to  Eq.  1.  The  platelets  being  at 
equilibrium with respect to serotonin, and the amount of 
serotonin within the surrounding medium being known, 
the total  amount  of serotonin in  the two platelet com- 
partments  may  be calculated  as  follows: let S~  be the 
total amount of serotonin in compartment 1, S~ the total 
amount of serotonin in compartment 2, and $3 the total 
amount of serotonin in compartment 3, then (amount of 
serotonin in compartment  1) ￿  (fraction of serotonin in 
compartment  I  transferred  to  compartment  2  every 
minute) 
=  flux from  I to 2  =  a~,S~ 
similarly: 
flux from 2 to  1 =  a12S~. 
At equilibrium: 
(l~tSt  =  at2S2 
or~ 
S~ =  $1 a~l 
alz 
similarly: 
S~ = S~  a~. 
a23 
Although the aH data set cannot be used to calculate the 
fractional turnover rates, its initial distribution within the 
platelet being unknown, this data set is valuable in that 
the  equation  describing  it,  Eq.  2,  has  constants  in 
common with Eq.  1 (A, A~, and ,~2). 
The simultaneous fitting of both data sets to the Eqs. 1 
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constants. This fitting employs a  Bayesian multivariate 
technique of analysis. This method takes  into account 
the  correlation  between  the  errors  in  both data  sets. 
Details of this analytical technique will be published else- 
where  (Allen,  Reimers,  Feuerstein,  and  Mustard, 
manuscript submitted for publication). 
The analysis of the serotonin exchange experiments is 
based on the assumption that radioactive serotonin is not 
converted to other compounds to an appreciable extent 
during the experiment.  However, it has been shown by 
Pletscher (1968) that part of the endogenous serotonin is 
metabolized in the presence of platelets agglutinated by 
thrombin (0.8%  of the released serotonin was recovered 
as 5HT'ol after 30 min of incubation and 12.1% after 2 h 
of  incubation;  5HT'ol  was  identified  as  the  major 
metabolite  in  his  studies).  We  confirmed  Pletscher's 
finding  that  the  formation  of  metabolic  breakdown 
products is enhanced by treating platelets with thrombin. 
However, we determined that the breakdown products of 
serotonin would introduce errors only in the presence of 
much lower concentrations of serotonin than the 123 ~tM 
concentration  used  in  the  exchange  experiments.  For 
example:  upon  addition  of  a  low  concentration  of 
[14C]5HT  (2  tzM),  3.5%  of  the  added  serotonin  was 
metabolized within I h to the major breakdown products 
5HIAA  and  5HT'ol  in  the  control  platelets,  whereas 
34.8%  was  metabolized  in  the  presence  of  thrombin- 
treated  platelets.  However,  upon  the  addition  of  the 
much  higher  concentration  of  serotonin  used  in  the 
exchange experiments (123 #M),  there was  no statisti- 
cally significant breakdown of serotonin into its metabo- 
lites (expressed as a percentage of the added serotonin) 
during the time-course of the experiments. The highest 
calculated  (but  not  significant) breakdown  of  123 ~M 
serotonin in the  presence of thrombin-treated platelets 
was 1.3% per hour. It was calculated that a breakdown at 
this rate had only a  small effect (less than  15%) on the 
values calculated for the serotonin transport rates com- 
pared to those calculated by assuming no breakdown of 
serotonin. 
In  addition,  the  analysis  of the  serotonin exchange 
experiments assumes that the exchange of radioactivity 
represents exchange of serotonin and not of radioactive 
breakdown products.  However,  the [14C]5HT  used had 
some radiochemical impurities a~, shown by paper chro- 
matography. The largest impurity was due to 5HIAA (up 
to  6%  of  the  total  radioactivity).  An  experiment  was 
done, therefore, in which the uptake of [~'C]5HIAA by 
platelets was examined, it was found that, independent of 
the  [~'C]SHIAA  concentration used  (0.5  or  5.0 jaM), 
about  10% of the radioactivity became associated with 
both  the  control  platelets  and  the  thrombin-treated 
ptatelets within 2 min. There was no further accumula- 
tion of radioactivity within the platelets during the next 
hour. Since the 5HIAA impurity was less than 6% in the 
serotonin used,  nonspecific uptake of radioactivity could 
not exceed 0.6% of the added radioactivity. Furthermore, 
the exchange process was only analyzed between 2 and 50 
min after addition of [t4C]5HT  to the suspending me- 
dium. 
It  was  also calculated  that  an error of  •  in the 
determination  of  the  purity  of  the  [1~C]5H'1" did  not 
appreciably alter the values calculated for the serotonin 
exchange rates, provided the breakdown products do not 
participate in the exchange process (see above). 
Electron Microscopy 
Platelets for electron microscopy were fixed  in 2.5% 
glutaraldehyde at 4~  for 30 min, washed in Millonig's 
buffer, and postfixed in  1% osmium tetroxide (4~  20 
min). The fixed  platelets were dehydrated in increasing 
concentrations  of  ethanol,  and  embedded  in  Spurr's 
resin. Sections were cut with an LKB microtome, stained 
with uranyl acetate and lead citrate, and examined on a 
Philips 300 electron microscope. 
RESULTS 
Reaccumulation of Serotonin after a Single 
Thrombin-lnduced Release Reaction 
Washed  rabbit platelets labeled  with  [~4C]5HT 
(I.2  ~tM)  aggregate  upon  addition  of  thrombin 
(0.05  U/ml)  and  release  between  20  and  40%  of 
their radioactivity. In the absence of apyrase in the 
suspending  medium  these  platelets remain  aggre- 
gated  for  at  least  15  rain  and  the  amount  of the 
radioactivity  in the surrounding  medium  remains 
almost  unaltered  over  this period  (Fig.  1).  How- 
ever, upon the addition of PGE~ (1  uM),  platelets 
deaggregate  rapidly and the majority of the radio- 
activity is taken up from the surrounding medium 
within approximately 30-60 min (Fig.  1). PGE~ (1 
uM) by itself does  not influence serotonin uptake 
into  rabbit platelets under the conditions of these 
experiments. 
The effect of the concentration of serotonin used 
to  label  platelets  on  their  ability  to  accumulate 
serotonin  after  the  release  reaction  was  investi- 
gated.  A  suspension  of  washed  rabbit  platelets 
(109/ml)  was  incubated  with  a  high  serotonin 
concentration (123 #M) for 60 min. (This time was 
chosen because no further net uptake of serotonin 
occurred after 20 min.) During this incubation the 
serotonin  content  of  these  platelets  rose  from 
approximately 75 nmol/109 platelets to  123 nmol/ 
109  platelets.  Upon  addition  of  thrombin  (0.05 
U/ml), these platetets released approximately 25% 
of their [14C]5HT. This is similar to the percentage 
[t'C]5HT released by thrombin treatment of plate- 
lets  incubated  with  a  low  concentration  of  sero- 
tonin (1.2 #M). (These platelets contained 80 nmol 
~62  THE  JOURNAL OF  BIOLOGY  .  VOLUME  65,  1975 of serotonin/10 ~ platelets  before  thrombin  treat- 
ment.) The percentage of serotonin reaccumulated 
by  the  platelets  during  the  first  30  rain  after 
deaggregation was greater if the platelets had been 
incubated  with  a  low serotonin  concentration  be- 
fore  the  release  reaction  (Fig.  2).  The  rate  of 
serotonin  reaccumulation  was calculated  from the 
specific  activity  of  the  serotonin  present  in  the 
platelets  before the  release  reaction  and  from  the 
disappearance  rate  of  "C  from  the  surrounding 
medium. The rate of serotonin reaccumulation was 
334  pmol/min/10  ~ platelets for the suspension  of 
platelets  labeled  in  the  presence  of  123  #M 
[I'C]5HT and  584 pmol/min/10 ~ platelets for the 
platelets  labeled  in  the  presence  of  1.2  #M 
["C]SHT. 
The effect of the concentration  of thrombin  on 
the  ability of platelets  to  reaccumulate  serotonin 
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FIGURE  1  Comparison of reuptake of ["C]SHT by thrombin-treated platelets.  Platelet aggregation and 
release was induced with thrombin (0.05 U/ml). 5 min after the addition of thrombin, either PGE, (1/~M) 
and TAMe (I mM) or Tyrode solution (control) and TAMe (1 mM) were added to the platelet suspension. 
The amounts of ["C]5HT in the supernates of aliquots of the suspension  in which deaggregation had been 
induced  by PGEt (~-  g) and  in the control suspension  (r-I  I-1) were determined. 
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14  Reuptake of ["C]5HT after thrombin-induced release  of [  C]serotonin from rabbit platelets 
prelabeled with  different amounts  of serotonin.  Platelets were labeled  in the presence  of either  1.2 ~M 
["C]5HT (1  I) or 123 #M [~'C]5HT (O---O). Platelet aggregation and release were induced in both 
suspensions  with thrombin (0.05 U/ml). After 5 min, PGE~ (1 tzM) and TAMe (I mM) were added to the 
suspension  to cause platelet deaggregation. The percentages of radioactivity in the supernates  from ali- 
quots of the two suspensions  were determined. 
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shows  one  of three  similar experiments  in  which 
platelets that had been incubated in the presence of 
a  high concentration  of [I'C]5HT  (123  uM) were 
stimulated  with  two  different  concentrations  of 
thrombin  (0.5  and 0.05  U/ml). The percentage of 
[t4C]5HT  reincorporated  per  minute  into  the 
platelets after deaggregation with PGEa was iden- 
tical under these conditions. 
Reaccumulation of  Serotonin after Repeated 
Thrombin-lnduced Release Reaction 
When platelets were treated with thrombin (0.05 
U/ml) three  times,  their serotonin  content  fell to 
about  20%  of  the  initial  value  (Table  I).  Upon 
incubation with serotonin (123 t~M), these platelets 
were  still able  to  accumulate  serotonin  against  a 
concentration gradient of approximately 50:1. This 
was calculated on the assumption that  109 platelets 
occupy  a  volume of approximately  10 ttl  and  the 
observation  that  thrombin-treated  platelets  con- 
tain  56  nmol of serotonin/109  platelets after they 
have been  incubated  with  123 ttM  serotonin.  The 
total  amount  of serotonin  that  could  be accumu- 
lated  by these  thrombin-treated  platelets  was  ap- 
proximately  40%  of  the  amount  that  could  be 
accumulated  by  the  untreated  control  platelets 
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(Table  I).  When  thrombin-treated  platelets  were 
incubated  with  lower concentrations  of serotonin 
(0.4 #M),  they were able to accumulate serotonin 
against  a  concentration  gradient  of greater  than 
3,000:1.  The total amount  of [14C]serotonin  accu- 
mulated  in  30  min  by  thrombin-treated  platelets 
and  untreated  control  platelets  was  less  in  the 
presence  of either  imipramine  (20 uM)  or  reser- 
pine  (2  vM)  (Fig.  4).  Reserpine  decreased  the 
apparent  initial  rate  of  serotonin  uptake  by  the 
untreated  control  platelets  but  not  by  thrombin- 
treated  platelets:  initial  rates  of serotonin  uptake 
were similar  with both types of platelets.  The ap- 
parent  initial  rates  of  serotonin  uptake  in  the 
presence  of imipramine  were  similar with throm- 
bin-treated  platelets  and  untreated  control 
platelets (Fig. 4). 
Storage Capacity and Subcellular 
Compartmentation of Serotonin after the 
Thrombin-lnduced Release Reaction 
There are three possible reasons why thrombin- 
treated platelets do not store as much serotonin as 
the  unstimulated  control  platelets:  (a)  thrombin 
damages  the  uptake  mechanism  for  serotonin 
(influx),  (b)  there  is  an  increased  rate  of  loss 
(efflux)  of  serotonin  because  of  increased  mere- 
Thrombin 
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MINUTES 
Reaptake  of ["C]5HT  by  rabbit  platelets after induction of the release reaction  with  two 
thrombin concentrations.  Platelet aggregation and  release were induced  with either 0.05 U/ml thrombin 
(m  m) or 0.5 U/ml thrombin (O  ￿9  5 rain after the addition of thrombin, PGE: (I uM), TAMe (1 
raM),  and  plasmin  (0.5  mg/ml)  were  added  (at  the  points  indicated  by  the  arrows)  to  facilitate 
deaggregation. The percentage of [:~C]5HT  in the supernates  of aliquots of the suspensions  was measured. 
Linear  regression  was  employed  to  determine  the  fractional  rate  of  reuptake  of serotonin  from  the 
suspending  medium  into the  platelets.  The  regression  was  significant  in  all three experiments done (P 
<0.025,  F-test  after  analysis  of variance).  When  the  data  obtained  with  the  two  different  thrombin 
concentrations were compared, it was found that the mean square for departures from parallelism was less 
in all cases than the estimate of variance of the data. Therefore the fractional rate of reuptake of "C was the 
same, independent  of the thrombin concentration used. 
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Serotonin Uptake by Washed  Rabbit Platelets 
Significance 
Thrombin- of difference 
Control  treated  between 
platelets*  platelets  means 
Platelet serotonin 
content before  in- 
cubation with ex- 
ogenous serotonin 
Platelet serotonin 
content upon in- 
cubation with ex- 
ogenous serotonin 
(123~tM) 
nmol/lO" platelet  s 
74 •  16  15 •  2 
(3)  (4) 
P < 0.02 
132 •  7  56 •  9  P <0.001 
(4)  (4) 
Means and standard error of means. The number of experiments 
is indicated in parentheses. 
* The serotonin content of platelets before any treatment was 74 
-*- 4 nmol/109 platelets (mean •  SE of 10 experiments). 
brane  permeability  of the  platelet  plasma  mem- 
brane,  or (c) there is a  decreased  storage capacity 
within  the  platelets  after  the  thrombin-induced 
release reaction. 
These three possibilities were examined in exper- 
iments  in  which  the  influx  of  serotonin  into  the 
platelets  and  the  efflux  of  serotonin  from  the 
platelets  were  determined  simultaneously.  Plate- 
lets  were equilibrated  with  [3H]5HT  at  a  concen- 
tration  of  123  aM  in  the  suspending  fluid  for  60 
min and then resuspended in fresh Tyrode solution 
containing  albumin  and  apyrase.  The  suspension 
was divided  into two  parts.  One part  was treated 
three  times  with  thrombin  (0.05  U/ml),  and  the 
other  part  (control)  was  treated  with  Tyrode 
solution  instead  of  thrombin.  After  the  third 
deaggregation, thrombin-treated  platelets and con- 
trol  platelets  were  again  equilibrated  with  a  high 
concentration of [3H]5HT (123/zM) for 30 min at 
37~  Platelets  were  recovered  by centrifugation 
and  resuspended  in  Eagle's  medium  containing 
albumin (0.35%) and apyrase so that [aH]5HT was 
essentially  only  inside  the  platelets.  [I'C]5HT  at 
the same final concentration  (123 #M) was added 
to  the  suspending  medium.  Therefore  no  further 
net  loss  or  net  uptake  could  occur.  However, 
exchange  of  serotonin  between  the  surrounding 
medium  and  the  platelets  continued  under  these 
conditions (Fig. 5).  [I'C]5HT was taken  up by the 
platelets  and  [aH]5HT  accumulated  in  the  sus- 
pending  medium.  This exchange did  not occur at 
4~  (Fig. 5).  All experiments were stopped 50 min 
after  addition  of  the  [~4C]5HT  because  in  the 
suspension  of  thrombin-treated  platelets  the  pH 
fell below 7.2  (thrombin-treated  platelets produce 
about twice as much lactate per minute under these 
conditions  as  unstimulated  control  platelets 
[Reimers et al.,  1973]). 
The  data  were  analyzed  using  the  hypothesis 
that at equilibrium the amount of serotonin trans- 
ported  per minute  from  the surrounding  medium 
into the cytoplasm equals the amount of serotonin 
transported  from the cytoplasm into the surround- 
ing  medium.  Similarly,  the  amount  of serotonin 
transported  per  minute  across  the  amine  storage 
organelle membrane is the same in both directions. 
The  results  of our  analysis  of these  experiments 
using [3H]5HT and [~~  are shown in Tables 
II  and  III.  The  amount  of serotonin  transported 
per minute from the surrounding  medium into the 
cytoplasm did not differ significantly in thrombin- 
treated platelets and in unstimulated control plate- 
lets.  In  contrast,  the  amount  of serotonin  trans- 
ported  per  minute  from  the  cytoplasm  into  the 
amine storage granules  in thrombin-treated  plate- 
lets  was  approximately  40%  of  that  in  the  un- 
stimulated control platelets.  In addition,  it can be 
seen  in Table  II that  the percentage  of the amine 
storage granule serotonin that  was transferred  per 
minute  into  the  cytoplasm  was  not  significantly 
greater  in  the  thrombin-treated  platelets  than  in 
the unstimulated  control platelets. The percentage 
of the cytoplasmic serotonin  transferred  per min- 
ute into the surrounding  medium  was  not greater 
in  the thrombin-treated  platelets than  in the con- 
trol platelets. The absolute amounts of serotonin in 
the  cytoplasm  and  in  the  amine  storage  granules 
were  calculated  from  the  amount  of serotonin  in 
the suspending medium and the fractional turnover 
rates of serotonin between these compartments  for 
the  equilibrium  conditions  (Table  III).  The 
amount  of serotonin  in the cytoplasm was similar 
in  thrombin-treated  platelets  and  unstimulated 
control  platelets,  whereas  the serotonin  bound  in 
the amine storage granules was reduced by approx- 
imately 70-75%  in the thrombin-treated  platelets. 
Release of Serotonin from  Platelets 
Treated Three Times with  Thrombin and 
Incubated with Serotonin 
The difference in the amounts  of serotonin held 
in  the  storage  granules  of platelets  treated  three 
times  with  thrombin  and  control  platelets  should 
be reflected in the percentage of serotonin that can 
be released upon maximal stimulation with throm- 
bin.  Whereas  after  reloading  with  serotonin  (123 
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Effect of Thrombin  Treatment  of Washed Rabbit Platelets on Serotonin  Exchange between Different Platelet 
Compartments  and Suspending  Medium 
Thrombin- 
Control  treated  Significance  of difference 
platelets  platelets  between means* 
Percent of serotonin in the suspending  medium 
transferred into the cytoplasm per minute 
Percent of serotonin in the cytoplasm trans- 
ferred into the suspending  medium per 
minute 
Percent of serotonin in the cytoplasm trans- 
ferred into the amine storage granules per 
minute 
Percent of serotonin in the amine storage 
granules transferred into the cytoplasm per 
minute 
7.0  6.8  P >0.05 
(Not significant) 
64.8  49.7  P >0.05 
(Not significant) 
28.0  7.6  P <0.05 
(Significant) 
2.0  2.6  P >0.05 
(Not significant) 
Means of three experiments. 
* In these studies, serotonin transport has been described by nonlinear equations containing several constants. These 
constants are highly correlated. Significance of the change in their values upon thrombin treatment was assessed 
through the following tests: (a) paired t-test, (b) t-test upon the estimates of the values of the constants for each 
experiment, the covariance matrix for the constants being determined by linearization in the region of the maximum 
likelihood estimate of the constants, (c) direct determination of 95% joint confidence contours for the estimated 
values in each experiment. 
/zM)  the  control  platelets  released  88%  of their 
[14C]5HT,  thrombin-pretreated platelets  released 
significantly less (68%) of their radioactivity upon 
incubation with a high thrombin concentration (0.5 
U/ml)  (significance of difference  between  mean 
percentage release for control [88  ~  3] and mean 
percentage  release  for  thrombin-treated platelets 
[68 ~- 2J: P  <0.001, mean of six experiments). On 
the  assumption  that  the  released  radioactivity 
represents  the  serotonin  in  the  amine  storage 
granules, whereas the retained radioactivity repre- 
sents primarily cytoplasmic serotonin (and possi- 
bly some  of its  metabolic breakdown  products), 
one can calculate from the data in Table 1 that the 
cytoplasmic  compartment  contains  18  nmol  of 
serotonin/10  ~ platelets  in  the  case  of thrombin- 
treated  platelets  and  16  nmol  of  serotonin/10  ~ 
platelets  in  unstimulated  control  platelets  (P 
<0.7). 
Morphology  of Thrornbin- Treated Platelets 
Platelets that had been treated three times with a 
low  concentration of thrombin (0.05  U/ml) and 
untreated control platelets were prepared for elec- 
tron microscopy. Fig. 6 shows that the thrombin- 
treated  platelets had  lost  most  of their electron- 
dense (amine storage) organelles and many of their 
c~-granules,  whereas  their mitochondria appeared 
to be retained. 
Thrombin-treated platelets and  untreated con- 
trol platelets were incubated for 45 min with a high 
concentration  of  serotonin  (123  /~M) and  then 
fixed, stained, sectioned, and examined by electron 
microscopy.  The  numbers  of  electron-dense 
(amine storage) organelles in sections of platelets 
before and after exposure to serotonin were com- 
pared (Table I V). The control platelets (not treated 
with thrombin)had an increased number of visible 
amine  storage  organelles  after  they  had  been 
exposed  to  a  high  concentration  of  serotonin 
whereas  thrombin-treated platelets  showed  little 
increase.  It can be calculated from Table IV that 
the number of visible amine storage organelles in 
thrombin-treated platelets was reduced by 79% in 
this experiment. 
DISCUSSION 
We have shown previously (Reimers et al.,  1973) 
that thrombin-induced platelet aggregates can be 
deaggregated by the addition of PGE~ and hirudin 
or  TAMe,  even  if  the  platelets  have  released 
30-40% of their amine storage granule contents. In 
the present experiments, it was observed that the 
released serotonin was almost completely taken up 
again by the platelets as they deaggregated. Even 
after three treatments with low concentrations of 
thrombin which  resulted in loss  of 70  80% of the 
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Effect of Thrombin Treatment of Washed Rabbit 
Platelets on Serotonin Storage Capacity and on 
Serotonin Exchange Rate between Different Platelet 
Compartments and Suspending Medium 
Significance 
Thrombin-  ofdifference 
Control  treated  between  the 
platelets  platelets  means 
Cytoplasmic 
compartment 
Amine  storage 
granule com- 
partment 
Serotonin ex- 
change rate 
between cy- 
toplasm and 
amine stor- 
age granules 
Serotonin ex- 
change rate 
between sus- 
pending 
medium  and 
cytoplasm 
nmol/ I0  ~  platelets 
12:~3  16:~4  P<0.2 
146 :~ 10  40 ~  6  P  <  0.01 
nmol/min/ lO  ~ platelets 
2.86 :~ 0.52  1.06 + 0.20  P <0.05 
8.60 ~: 3.23  8~39 • 0.52  P <0.95 
Means •  SE of means of three experiments;  paired t-test. 
endogenous serotonin, platelets were  able to take 
up serotonin from the surrounding medium. 
Degranulation of platelets by thrombin might be 
expected  to  decrease  the  ability  of  platelets  to 
accumulate  serotonin.  This  is  based  on  the  as- 
sumption that when platelets have been exposed to 
thrombin  they  may  have  a  decreased  granule 
capacity  for  storing  serotonin,  or  a  decreased 
ability to take up serotonin due to damage of the 
serotonin  uptake  mechanism.  Alternatively,  an 
increased diffusion of serotonin from the platelets 
into  the  surrounding medium  could  result  in  a 
decrease in platelet serotonin. 
A fundamental consideration in the design of the 
experiments to investigate these possibilities is the 
relationship  between  serotonin  uptake  and  ex- 
change. When platelet serotonin is in equilibrium 
with  the  serotonin  in  the  suspending  medium, 
exchange  of serotonin between the  platelets  and 
the  surrounding medium  continues; the  rate  of 
exchange is the same as the rate at which serotonin 
is taken up initially (Born and Gillson, 1959). In 
experiments in which we studied serotonin trans- 
port,  the  platelets  were  first  incubated  with 
[SH]5HT  until  no  further  net  uptake  occurred. 
Because these studies were done under equilibrium 
conditions, it was  possible to estimate the trans- 
port rates of serotonin across the platelet plasma 
membrane  as  well  as  to  estimate  the  absolute 
amounts  of  serotonin in  the  cytoplasm  and  the 
amine storage organeiles (Allen, Reimers, Feuer- 
stein,  and  Mustard,  manuscript  submitted  for 
publication). 
Analysis of the serotonin exchange experiments 
with  thrombin-treated  platelets  and  untreated 
platelets  showed  that  serotonin transport  across 
the platelet membrane into the cytoplasm was not 
altered  by  thrombin  treatment.  Normal  human 
platelets can take up serotonin against a concen- 
tration gradient of more than  1,000:1 (Born and 
Gillson,  1959).  In  our  experiments,  thrombin- 
stimulated rabbit platelets were also found to take 
up  serotonin against a  concentration gradient of 
more than 1,000:1 (we did not determine the upper 
limit of the gradient against which serotonin could 
accumulate). These calculations are based on the 
assumption  that  the  total  platelet  serotonin  is 
present  in  a  single  compartment,  and  do  not 
indicate the  actual serotonin gradient across  the 
platelet plasma membrane against which serotonin 
is taken up from  the  suspending medium. In the 
experiments reported  here,  we  were  able to  esti- 
mate the serotonin concentration in the intermedi- 
ate (cytoplasmic) compartment. From these data it 
can  be  calculated  that,  under  our  experimental 
conditions, serotonin was  transported  across  the 
platelet  plasma  membrane against a  gradient of 
approximately  10:1. Furthermore,  serotonin ex- 
change  by  the  thrombin-treated  platelets  was 
nearly completely inhibited if they  were  kept  at 
4~  These  observations are in keeping with the 
hypothesis that, at 37~  serotonin uptake by these 
platelets is at least in part an active process. 
The studies with inhibitors of serotonin accumu- 
lation  in  platelets  provided  additional evidence 
that the mechanism and rate of serotonin transport 
across the plasma membrane of platelets are not 
altered  by  thrombin  treatment.  Imipramine,  a 
drug  known  to  affect  serotonin  uptake  at  the 
plasma  membrane  (Da  Prada  and  Pletscher, 
1968),  reduced  the  apparent  initial rate  of sero- 
tonin accumulation by thrombin-treated platelets 
and by untreated control platelets; in the presence 
of imipramine, the apparent initial rates of sero- 
tonin uptake were similar. Likewise, the apparent 
initial rates of serotonin accumulation by throm- 
bin-treated platelets and untreated control plate- 
lets  were  similar in  the  presence  of reserpine,  a 
drug that specifically inhibits the incorporation of 
serotonin into platelet granules but does not inhibit 
368  THE JOURNAL OF BIOLOGY . VOLUME 65,  1975 FIGURE  6  Electron  micrographs  of  platelets  after  exposure  to  a  high  concentration  (123  ~tM)  of 
exogenous serotonin: (a) control platelets, (b) platelets that had been treated three times with 0.05  U/ml 
thrombin before incubation for 45  rain in the serotonin-containing medium. (a)  ￿  9,800;  (b)  x  11,100. 
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Electron-Dense (Amine Storage) Organelles in 
Washed Rabbit Platelets 
Electron-dense  organelles 
Mean number  of elec- 
tron-dense  organdies  per 
100 platelet  sections* 
Th~ombin- 
Control  treated 
platelets  platelets~ 
Before incubation with ex-  101  28 
ogenous serotonin 
After incubation with exog-  159  33 
enous serotonin ( 123 ~M) 
* Based on at least five grids per platelet sample. More 
than  250 platelet sections were counted for each value 
given in Table IV. 
Platelets had been treated three times with 0.05 U/ml 
thrombin before incubation for 45 min in the se.rotonin- 
containing medium. 
serotonin  transport  across  the  platelet  plasma 
membrane (Da Prada and Pletscher,  1968; Weiss 
et al.,  1974). 
Analysis of  the  data  from  these  experiments 
showed  that  thrombin treatment of platelets did 
not significantly change the  fraction of cytoplas- 
mic serotonin which  diffused into the suspending 
medium  per  unit  time.  Thus,  it  appears  that 
thrombin treatment under the conditions of these 
experiments does not alter the  membrane uptake 
mechanism, nor does  it  increase the diffusion of 
serotonin into the suspending medium. 
The main reason for the diminished accumula- 
tion of serotonin in the thrombin-treated platelets 
is a decreased transfer rate of serotonin from the 
cytoplasm into the  platelet amine storage organ- 
elles.  The most likely explanation for this is that, 
after  thrombin-induced degranulation, there  are 
fewer  granules or granule-binding sites  available 
for serotonin. Two-thirds of the serotonin storage 
capacity  of  the  thrombin-treated  platelets  ap- 
peared to be located in the granules because only 
two-thirds of the serotonin could be released upon 
the addition of a high concentration of thrombin. 
The  results  from  the  serotonin exchange experi- 
ments  using  thrombin-treated  platelets  also  in- 
dicated  that,  under  the  present  experimental 
conditions, about one-third of the serotonin is in 
the  small  compartment  (cytoplasm)  and  two- 
thirds  in  the  large  compartment (amine storage 
granules). These results do not imply that there is 
this much  serotonin present  in the  platelet cyto- 
plasm  under physiological conditions in vivo.  In 
the experiments reported here, high serotonin con- 
centrations  were  present  in  the  suspending 
medium  (123  ~M).  The  high  serotonin concen- 
tration was chosen to ensure that there be no ap- 
preciable  net  movement of  serotonin across  the 
platelet  plasma  membrane and  to  minimize the 
(relative)  formation  of  serotonin  breakdown 
products  during  the  exchange  experiments  (see 
Materials  and  Methods).  These  conditions were 
essential for later analysis. There is no doubt that 
the concentration of serotonin in the platelet cyto- 
plasm  will  be  lower  under  physiological  condi- 
tions  because  the  concentration  of  serotonin  in 
the  blood plasma is  extremely low  and  a  differ- 
ent  equilibrium  situation  between  cytoplas- 
mic serotonin and serotonin in the blood plasma 
will  be  established.  In  addition,  it  should  be 
pointed  out  that  the  cytoplasmic serotonin pool 
probably does not reflect  an alternative serotonin 
storage compartment since small amounts of sero- 
tonin are relatively rapidly metabolized by throm- 
bin-treated ("degranulated") platelets (see  Mate- 
rials and Methods) or by unstimulated platelets in 
the presence of reserpine (Pletscher,  1968). How- 
ever, the high  concentrations of serotonin used  in 
these  experiments  allowed  us  to  estimate  the 
maximum transport rates of serotonin between the 
different compartments which  would otherwise be 
impossible with presently available techniques. 
Analysis of  the  data  from  the  serotonin  ex- 
change  experiments  indicated  that  the  serotonin 
capacity of the larger platelet pool (granule pool) 
was reduced by approximately 73% upon thrombin 
treatment. Electron micrographs showed  that the 
number of electron-dense granules (amine storage 
organelles) in sections of thrombin-treated plate- 
lets  was  reduced  by  approximately  79%  when 
compared with the untreated control platelets. 
It is possible that  with  thrombin-treated plate- 
lets some of the granule membranes are reutilized 
but that the binding affinity for serotonin may be 
diminished because of the lack of ATP with which 
serotonin is thought to form complexes (Berneis et 
al.,  1971). This hypothesis of partial reutilization 
of amine storage granule membranes could explain 
the  observations in  the  present  study that  some 
uptake  of [I*C]5HT  occurred  after  the  platelets 
had  been  exposed  to  a  high  concentration  of 
thrombin. This reuptake of [~C]5HT took  place 
after thrombin stimulation even if the platelets had 
been incubated with  a high concentration of sero- 
tonin before stimulation. "Preloading" the plate- 
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into  amine  storage  granules  which  had  not  dis- 
charged contents upon thrombin stimulation. 
We have previously shown that platelets which 
have  been  repeatedly  stimulated  with  thrombin 
survive  in  the  circulation  for  the  same  length  of 
time  after  reinfusion  as  platelets  which  have not 
been  subjected  to  thrombin  treatment.  We  have 
also  obtained evidence (Reimers et al.,  1974) that 
cytoplasmic  ATP  can  be  transferred  into  the 
amine storage granules and that exchange between 
cytoplasmic  and granule  ATP  is complete  within 
24 h. Taken together, the results raise the possibil- 
ity that amine storage granules or granule contents 
may  be  reconstituted  in  vivo  after  the  release 
reaction. 
The  mechanism  by  which  serotonin  is handled 
by these  thrombin-treated  platelets appears to  be 
similar  to  that described  for  platelets  from  some 
patients  with  albinism  or  storage  pool  disease 
(Hardisty and Mills,  1972; Weiss et al.,  1974). It is 
possible that some conditions of acquired storage 
pool disease may represent the consequence of in 
vivo  release  reactions.  There  has  been  a  report 
indicating that this does occur in man (Zahavi and 
Marder,  1974). 
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